Order Mucorales (mucormycosis)
Family Mucoraceae
Absidia (Absidia corymbifera)
Apophysomyces (Apophysomyces elegans and Apophysomyces trapeziformis)
Mucor (Mucor indicus)
Rhizomucor (Rhizomucor pusillus)
Rhizopus (Rhizopus oryzae)
Family Cunninghamellaceae
Cunninghamella (Cunninghamella bertholletiae)
Family Thamnidiaceae
Cokeromyces (Cokeromyces recurvatus)
Family Saksenaeaceae
Saksenaea (Saksenaea vasiformis)
Family Syncephalastraceae
Syncephalastrum (Syncephalastrum racemosum)
Order Entomophthorales (entomophthoramycosis)
Family Basidiobolaceae
Basidiobolus (Basidiobolus ranarum)
Family Ancylistaceae
Conidiobolus (Conidiobolus coronatus/Conidiobolus incongruus)

Epidemiology
Zygomycosis has been found in survivors of the 2004 Indian Ocean earthquake and tsunami and in survivors of the 2011 Joplin, Missouri tornado. Symptoms
In the primary cutaneous form, the lesions are usually painful and necrotic, with black eschar, accompanied by a fever. Patients will usually present with a history of poorly controlled diabetes or malignancy. Myocutaneous infections may lead to amputation. Pulmonary tract infections seen with lung transplant patients, who are at high risk for fatal invasive mycoses. Rhinocerebral infection is characterized by paranasal swelling with necrotic tissues. Patient may have hemorrhagic exudates (tissue fluid from lesions tinged with blood) from the nose and eyes as the fungi penetrate through blood vessels and other anatomical structures. Diagnosis
Diagnosis is done with potassium hydroxide (KOH) preparation in tissue. On light microscopy, there will be broad, ribbon-like septate hyphae with 90 degree angles on branches. KOH wet mount of the black eschar will show aseptate fungal hyphae with right angle branching. Periodic Acid Schiff (PAS) staining will reveal similar broad hyphae in the dermis and cutis. Fungal culture can also confirm the organism. Diagnosis remains difficult due to the lack of laboratory tests as mortality remains high.
Pricing
The British Competition and Markets Authority launched an investigation into the alleged "excessive and unfair pricing" of liothyronine tablets in 2017. It alleged that Advanz Pharma overcharged the NHS from before 2007 to July 2017. The price of a pack increased by almost 1,600% from £4.46 before it was debranded in 2007 to £258.19 by July 2017. References
External links
"Liothyronine". Drug Information Portal. U.S. National Library of Medicine.